Effect of Cisplatin on Ultrastructure and Viability of Adipose-Derived Mesenchymal Stem Cells
- 19 September 2016
- journal article
- research article
- Published by Springer Nature in BioNanoScience
- Vol. 6 (4) , 534-539
Abstract
No abstract availableKeywords
Funding Information
- Russian Foundation for Basic Research (16-34-60201)
This publication has 15 references indexed in Scilit:
- Cisplatin in cancer therapy: Molecular mechanisms of actionEuropean Journal of Pharmacology, 2014
- Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymal stem cellsToxicology Letters, 2014
- Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia‐bearing miceBritish Journal of Haematology, 2013
- Toxicities of anticancer drugs and its managementInternational Journal of Basic & Clinical Pharmacology, 2012
- Mesenchymal Stromal Cells Primed with Paclitaxel Provide a New Approach for Cancer TherapyPLOS ONE, 2011
- Human adipose tissue derived mesenchymal stem cells are resistant to several chemotherapeutic agentsCytotechnology, 2011
- Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent ImagingStem Cells, 2009
- Bone Marrow-Derived Mesenchymal Stem Cells: Isolation, Expansion, Characterization, Viral Transduction, and Production of Conditioned Medium2009
- Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cellsGene Therapy, 2008
- Fat tissue: an underappreciated source of stem cells for biotechnologyTrends in Biotechnology, 2006